Salimian J, Ahmadi A, Amani J, Olad G, et al. Safety and Immunogenicity of a Recombinant Receptor Binding Domain-Based Protein Subunit Vaccine (Noora Vaccine) Against COVID-19 in Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial. J Med Virol 2022 Aug 27. doi: 10.1002/jmv.28097.
PMID: 36029105